Abstract:Background: Neonatal diabetes mellitus (NDM) is a rare form of diabetes. We analyzed a novel insulin gene ( INS ) mutation of a Chinese permanent neonatal diabetes mellitus (PNDM) patient to explore the clinical and genetic characteristics and put forward some opinions on treatment and its long-term management. Case description: A proband was recruited who was diagnosed with permanent neonatal diabetes on his first day after birth. His clinical and follow-up data were collected for 10 years. All of the family members were given an oral glucose tolerance test. Whole exome sequencing was performed on the proband, and the genomic DNA of family members was used for verification by first-generation Sanger sequencing technology. The pathogenic variant was screened according to the American College of Medical Genetics and Genomics classification guidelines and the clinical phenotype of the patient. Diagnostic assessment: The proband was diagnosed on the first day after birth, presenting with low birth weight, progressive hyperglycemia, and insulin deficiency. His parents and grandfathers were confirmed to have normal blood sugar levels. A novel homozygous mutation of c.1T>C in the INS gene was detected in the proband, located in the initiation codon. The heterozygous mutations were found in four family members, including his mother, father, and grandfathers. With regular insulin injections, long-term regular follow-up, close monitoring of blood glucose, balanced exercise and diet, and psychological and mutual family support, the blood glucose level was well controlled; there were no acute or chronic complications during this decade. The patient's growth and nervous system development are now no different to those of the same age. Conclusion: A favorable prognosis is presented for a permanent neonatal diabetes mellitus (PNDM) patient with a novel mutation in the INS gene in China. The present findings indicate that the genetic diagnosis, early use of insulin, close monitoring of blood glucose, and psychological and mutual family support for patients with INS mutation are necessary for their favorable long-term prognosis.

Permanent Neonatal diabetes-causing Insulin mutations have dominant negative effects on beta cell identity

Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes

Permanent Neonatal Diabetes Mellitus in China

Aberrant Splicing of INS Impairs Beta-Cell Differentiation and Proliferation by ER Stress in the Isogenic iPSC Model of Neonatal Diabetes

A novel mutation in INS gene linked to permanent neonatal diabetes mellitus

The Levels of Pdx1/insulin, Cacna1c and Cacna1d, and Β-Cell Mass in a Rat Model of Intrauterine Undernutrition

Computational Analysis of Deleterious nsSNPs in INS Gene Associated with Permanent Neonatal Diabetes Mellitus

A Novel C.125 T>G (p.val42gly) Mutation in the Human INS Gene Leads to Neonatal Diabetes Mellitus Via a Decrease in Insulin Synthesis.

Insulin regulates human pancreatic endocrine cell differentiation in vitro

Case report: A 10-year prognosis of neonatal diabetes caused by a novel INS gene mutation

Defective Insulin Maturation in Patients with Type 2 Diabetes

Role of Proinsulin Self-Association in Mutant INS Gene-Induced Diabetes of Youth

A Novel Nonsense INS Mutation Causes Inefficient Preproinsulin Translocation Into the Endoplasmic Reticulum

A Novel Nonsense <i>INS</i> Mutation Causes Inefficient Preproinsulin Translocation Into the Endoplasmic Reticulum

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

A Kir6.2 mutation causing neonatal diabetes impairs electrical activity and insulin secretion from INS-1 beta-cells

IER3IP1 mutations cause neonatal diabetes due to impaired proinsulin trafficking

[Clinical and genetic analysis of an infant with permanent neonatal diabetes mellitus due to novel variant of insulin gene].

Proinsulin Misfolding and Endoplasmic Reticulum Stress During the Development and Progression of Diabetes☆

Investigating the pathogenicity of the recessive HNF1A p.A251T variant in monogenic diabetes using iPSC-derived beta-like cells

Insulin Therapy of Gestational Diabetes Does Not Fully Protect Offspring from Diet-Induced Metabolic Disorders.